DB75, a novel trypanocidal agent, disrupts mitochondrial function in Saccharomyces cerevisiae

Antimicrobial Agents and Chemotherapy
Charlotte A LanteriSteven R Meshnick

Abstract

The aromatic diamidines represent a class of compounds with broad-spectrum antimicrobial activity; however, their development is hindered by a lack of understanding of their mechanism of antimicrobial action. DB75 [2,5-bis(4-amidinophenyl)furan] is a trypanocidal aromatic diamidine that was originally developed as a structural analogue of the antitrypanosomal agent pentamidine. DB289, a novel orally active prodrug of DB75, is undergoing phase IIb clinical trials for early-stage human African trypanosomiasis, Pneumocystis jiroveci carinii pneumonia, and malaria. The purpose of this study was to investigate mechanisms of action of DB75 using Saccharomyces cerevisiae as a model organism. The results of this investigation suggest that DB75 inhibits mitochondrial function. Yeast cells relying upon mitochondrial metabolism for energy production are especially sensitive to DB75. DB75 localizes (by fluorescence) within the mitochondria of living yeast cells and collapses the mitochondrial membrane potential in isolated yeast mitochondria. Furthermore, addition of DB75 to yeast cells or isolated rat liver mitochondria results in immediate uncoupling of oxidative phosphorylation and subsequent inhibition of respiration. We conclude that ...Continue Reading

References

May 1, 1976·The Journal of protozoology·D Damper, C L Patton
Apr 1, 1977·Journal of Medicinal Chemistry·B P Das, D W Boykin
Oct 1, 1976·FEBS Letters·K E Akerman, M K Wikström
Jan 1, 1991·Methods in Enzymology·M P Yaffe
May 1, 1994·Antimicrobial Agents and Chemotherapy·G LudewigC Staben
Jul 6, 1993·Biochemistry·K JansenB Nordén
Feb 1, 1996·Archives of Biochemistry and Biophysics·S N Moreno
Oct 29, 1996·Proceedings of the National Academy of Sciences of the United States of America·J E CouryL A Bottomley
Jun 30, 2000·Journal of Molecular Biology·S MazurW D Wilson
Dec 29, 2000·Bioorganic & Medicinal Chemistry Letters·I J SimpsonS Neidle
May 12, 2001·Tropical Medicine & International Health : TM & IH·P CattandP Lucas
Jul 16, 2002·International Journal for Parasitology·Achim SchnauferKen Stuart
Jul 20, 2002·The Lancet Infectious Diseases·Dominique LegrosPhilippe Büscher
Mar 4, 2003·The Journal of Biological Chemistry·Lihua He, John J Lemasters
Apr 2, 2003·Fundamental & Clinical Pharmacology·Bernard BouteilleMichel Dumas
Aug 28, 2003·Current Opinion in Microbiology·Silvia N J Moreno, Roberto Docampo

❮ Previous
Next ❯

Citations

Jul 23, 2013·European Journal of Medicinal Chemistry·Donald A PatrickRichard R Tidwell
Jan 11, 2013·Journal of Medicinal Chemistry·Caitriona McKeeverIsabel Rozas
Jun 26, 2013·Journal of Medicinal Chemistry·Donald A PatrickRichard R Tidwell
Jun 2, 2010·The Journal of Antimicrobial Chemotherapy·Hiroshi NishikawaJunichi Mitsuyama
Nov 17, 2010·The Journal of Antimicrobial Chemotherapy·Hasan M S IbrahimHarry P de Koning
Jun 16, 2010·Antimicrobial Agents and Chemotherapy·Eio YamadaJunichi Mitsuyama
Dec 19, 2007·Antimicrobial Agents and Chemotherapy·Charlotte A LanteriSteven R Meshnick
Jan 30, 2008·Antimicrobial Agents and Chemotherapy·Junichi MitsuyamaHirokazu Narita
Sep 6, 2012·Antimicrobial Agents and Chemotherapy·Tatsuya ShibataJunichi Mitsuyama
May 16, 2009·Malaria Journal·Anne E PurfieldSteven R Meshnick
Jun 8, 2012·The Journal of Veterinary Medical Science·Bandula Kumara Wickramasekara RajapakshageMitsuyoshi Takiguchi
Nov 28, 2007·Expert Review of Anti-infective Therapy·Donald ChenJudith A Aberg
Mar 23, 2011·Expert Review of Anti-infective Therapy·Ozden Türel
Jul 19, 2005·Expert Opinion on Investigational Drugs·Dharmendar RathoreSanjai Kumar
Jul 30, 2005·Expert Opinion on Investigational Drugs·M N C SoeiroD W Boykin
Jan 13, 2015·Journal of Medicinal Chemistry·Wei ZhuEric Oldfield
Aug 22, 2015·ACS Infectious Diseases·Gyongseon YangJoo Hwan No
May 8, 2010·Colloids and Surfaces. B, Biointerfaces·Bochu WangLiancai Zhu
Aug 28, 2009·Fundamental & Clinical Pharmacology·Kesara Na-Bangchang, Juntra Karbwang
Jul 10, 2007·British Journal of Pharmacology·M P BarrettR R Tidwell
Jun 23, 2015·Tetrahedron Letters·Muhammad M KhalifaMichael M Haley
Jul 13, 2006·Memórias do Instituto Oswaldo Cruz·Renata B de OliveiraCarlos L Zani
May 9, 2008·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Man Chin ChungLorena Blau
Sep 8, 2016·Antimicrobial Agents and Chemotherapy·Gyongseon YangJoo Hwan No
May 4, 2005·Yeast
Jun 12, 2019·Antimicrobial Agents and Chemotherapy·Kohei YamashitaHiroshi Mukae
Aug 17, 2006·Molecular Pharmacology·Charlotte A LanteriMichael P Barrett
May 9, 2012·PLoS Neglected Tropical Diseases·Isabel M VincentMichael P Barrett
Feb 26, 2020·Tropical Medicine and Infectious Disease·Emily A DickieMichael P Barrett

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.